Will you have Short-term memory loss with Sandostatin lar - from FDA reports

Summary

Short-term memory loss is found among people who take Sandostatin lar, especially for people who are female, 60+ old , have been taking the drug for 2 - 5 years, also take medication Sandostatin, and have Neuroendocrine tumor. This study is created by eHealthMe based on reports of 21,554 people who have side effects when taking Sandostatin lar from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on octreotide acetate (the active ingredients of Sandostatin lar) and Sandostatin lar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Short-term memory loss are also considered in the study.

What is Sandostatin lar?

Sandostatin lar has active ingredients of octreotide acetate. It is often used in acromegaly. (latest outcomes from Sandostatin lar 21,605 users)

What is Short-term memory loss?

Short-term memory loss has been reported by people with multiple sclerosis, depression, pain, high blood pressure, high blood cholesterol (latest reports from 142,874 Short-term memory loss patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Feb, 19, 2019

21,554 people reported to have side effects when taking Sandostatin lar.
Among them, 582 people (2.7%) have Short-term memory loss


Number of reports submitted per year:

Could Sandostatin lar cause Short-term memory loss?

Time on Sandostatin lar when people have Short-term memory loss *:

  • < 1 month: 12.7 %
  • 1 - 6 months: 15.87 %
  • 6 - 12 months: 4.76 %
  • 1 - 2 years: 15.87 %
  • 2 - 5 years: 28.57 %
  • 5 - 10 years: 14.29 %
  • 10+ years: 7.94 %

Gender of people who have Short-term memory loss when taking Sandostatin lar *:

  • female: 64.84 %
  • male: 35.16 %

Age of people who have Short-term memory loss when taking Sandostatin lar *:

  • 0-1: 0.0 %
  • 2-9: 0.32 %
  • 10-19: 0.0 %
  • 20-29: 0.95 %
  • 30-39: 3.49 %
  • 40-49: 9.21 %
  • 50-59: 18.73 %
  • 60+: 67.3 %

Top conditions involved for these people *:

  1. Neuroendocrine Tumor: 124 people, 21.31%
  2. High Blood Pressure: 85 people, 14.60%
  3. Carcinoid Tumor: 68 people, 11.68%
  4. High Blood Cholesterol: 43 people, 7.39%
  5. Pain: 30 people, 5.15%
  6. Thyroid Diseases: 26 people, 4.47%
  7. Diabetes: 26 people, 4.47%
  8. Depression: 23 people, 3.95%
  9. Sleep Disorder: 21 people, 3.61%
  10. Pancreatic Neuroendocrine Tumor: 18 people, 3.09%

Top co-used drugs for these people *:

  1. Sandostatin: 55 people, 9.45%
  2. Synthroid: 52 people, 8.93%
  3. Metformin: 32 people, 5.50%
  4. Afinitor: 30 people, 5.15%
  5. Amlodipine: 28 people, 4.81%
  6. Calcium: 17 people, 2.92%
  7. Oxazepam: 16 people, 2.75%
  8. Lipitor: 16 people, 2.75%
  9. Dostinex: 16 people, 2.75%
  10. Morphine: 16 people, 2.75%

Top other side effects for these people *:

  1. Diarrhea: 214 people, 36.77%
  2. Malaise (a feeling of general discomfort or uneasiness): 202 people, 34.71%
  3. Fatigue (feeling of tiredness): 196 people, 33.68%
  4. Weight Decreased: 195 people, 33.51%
  5. Weakness: 183 people, 31.44%
  6. High Blood Pressure: 183 people, 31.44%
  7. Nausea (feeling of having an urge to vomit): 164 people, 28.18%
  8. Pain: 136 people, 23.37%
  9. Nausea And Vomiting: 131 people, 22.51%
  10. Abdominal Pain: 129 people, 22.16%

* Approximation only. Some reports may have incomplete information.

Do you have Short-term memory loss while taking Sandostatin lar?


You are not alone:




Related publications that referenced our studies

Related studies

Drugs that are associated with Short-term memory loss
Short-term memory loss (3,351 drugs)
Could your condition cause Short-term memory loss
Short-term memory loss (3,473 conditions)
Sandostatin lar side effects

Browse side effects by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Browse all side effects of Sandostatin lar
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Sandostatin lar and have Short-term memory loss



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!